Similar companies
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 241M | 2.7% |
| Gross Profit | 126M | 6.3% |
| Cost of Revenue | 115M | 1% |
| Operating expense | 178M | 25.8% |
| Net Income | -52M | 59.9% |
| EBITDA | -51M | 56.3% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 876M | 5% |
| Total Liabilities | 742M | 3.2% |
| Total Equity | 133M | 14.2% |
| Shares Outstanding | 67M | 1% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | -9.5M | 48% |
| Cash from investing | 58M | 532.8% |
| Cash from financing | -40M | 747.1% |
EPS
Financial Highlights for Tandem Diabetes Care in Q2 '25
Tandem Diabetes Care reported a revenue of 241M, which is a 2.7% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 126M, marking a 6.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 115M, a -1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 178M, showing a -25.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -52M, showing a 59.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -51M, showing a 56.3% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Tandem Diabetes Care with growth in revenue, gross profit, and net income.
